Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2311028121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Yidan Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Hauptthemen laut MEDLINE: Retina, Proanthocyanidins, Aging, Cellular Senescence. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key R&D Project of China, National Natural Science Foundation of China, Science and Technology Program of Guangzhou, China.
Abstract (Originalsprache)
Increased cellular senescence burden contributes in part to age-related organ dysfunction and pathologies. In our study, using mouse models of natural aging, we observed structural and functional decline in the aged retina, which was accompanied by the accumulation of senescent cells and senescence-associated secretory phenotype factors. We further validated the senolytic and senomorphic properties of procyanidin C1 (PCC1) both in vitro and in vivo, the long-term treatment of which ameliorated age-related retinal impairment. Through high-throughput single-cell RNA sequencing (scRNA-seq), we comprehensively characterized the retinal landscape after PCC1 administration and deciphered the molecular basis underlying the senescence burden increment and elimination. By exploring the scRNA-seq database of age-related retinal disorders, we revealed the role of cellular senescence and the therapeutic potential of PCC1 in these pathologies. Overall, these results indicate the therapeutic effects of PCC1 on the aged retina and its potential use for treating age-related retinal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, People's Republic of China.
- Department of Clinical Medicine, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510060, People's Republic of China.
ORCID-Profile: Yidan Liu, Xiuxing Liu, Xuhao Chen, Zhenlan Yang, Jianqi Chen, Weining Zhu, Yuwen Wen, Caibin Deng, Chenyang Gu, Jianjie Lv, Wenru Su
Förderung
- National Key R&D Project of China
- National Natural Science Foundation of China
- Science and Technology Program of Guangzhou, China
Zitieren
APA
Liu, Y., Liu, X., Chen, X., Yang, Z., Chen, J., Zhu, W., Li, Y., Wen, Y., Deng, C., Gu, C., Lv, J., Ju, R., Zhuo, Y., & Su, W. (2024). Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2311028121
Vancouver
Liu Y, Liu X, Chen X, Yang Z, Chen J, Zhu W, et al. Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2311028121
BibTeX
@article{Liu2024,
author = {Liu, Yidan and Liu, Xiuxing and Chen, Xuhao and Yang, Zhenlan and Chen, Jianqi and Zhu, Weining and Li, Yangyang and Wen, Yuwen and Deng, Caibin and Gu, Chenyang and Lv, Jianjie and Ju, Rong and Zhuo, Yehong and Su, Wenru},
title = {Senolytic and senomorphic agent procyanidin C1 alleviates structural and functional decline in the aged retina},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2311028121}
}
EUVIMED